On the dissociation pathways of copper complexes relevant as PET imaging agents

Area of Science:

• Inorganic Chemistry
• Radiopharmaceutical Chemistry
• Biophysical Chemistry

Background:

• Development of Copper-64 (⁶⁴Cu)-based PET agents requires highly stable and kinetically inert complexes.
• Common assays for metal-based PET probes include acid-assisted dissociation and transchelation challenges.
• The role of Cu(II)/Cu(I) bioreduction in complex dissociation is underexplored.

Purpose of the Study:

• To investigate the kinetic behavior of macrocyclic Cu(II) complexes using spectroscopic methods.
• To evaluate the stability of Cu(II) complexes under acidic conditions and in the presence of bioreductants.
• To explore the potential for Cu(II)/Cu(I) redox cycling to influence complex dissociation.

Main Methods:

• Synthesis and structural determination (X-ray diffraction) of macrocyclic Cu(II) complexes.
• Spectroscopic studies to analyze kinetic behavior.
• Acid-assisted dissociation tests using HClO₄ and HCl.
• Cyclic voltammetry to assess redox potentials.
• Dissociation studies in the presence of bioreductants like ascorbic acid.

Main Results:

• The cross-bridge cyclam derivative [Cu(CB-TE1A)]⁺ was structurally characterized.
• Acid-assisted dissociation rates were investigated, assessing the influence of counterions and complex charge.
• Cyclic voltammetry indicated bioreduction potentials for the Cu(II)/Cu(I) couple.
• [Cu(NO2Th)]²⁺ demonstrated exceptional inertness to acid-catalyzed dissociation.
• [Cu(NO2Th)]²⁺ exhibited rapid dissociation in the presence of ascorbic acid, a bioreductant.

Conclusions:

• The kinetic inertness of Cu(II) complexes is crucial for PET agent development.
• Bioreduction pathways, particularly with ascorbic acid, can significantly impact complex stability.
• [Cu(NO2Th)]²⁺ presents a unique dissociation profile, highlighting the importance of considering bioreductive environments.